# Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

> **NCT06584357** · — · RECRUITING · sponsor: **GAP Innovations, PBC** · enrollment: 1200 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer's Disease
- Alzheimer's Disease, Early Onset
- Memory Loss
- Memory Disorders
- Memory Impairment

## Interventions

- **OTHER:** Biomarker Data Collection
- **RADIATION:** MK6240

## Key facts

- **NCT ID:** NCT06584357
- **Lead sponsor:** GAP Innovations, PBC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-26
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584357, "Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06584357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*